Pulmonary Immunocompromise in Solid Organ Transplantation - 30/01/25
Doi : 10.1016/j.ccm.2024.10.011
Elizabeth A. Lendermon, MD a, Chadi A. Hage, MD, ATSF a, b, ⁎ 
a Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh Medical Center, 3459 Fifth Avenue, MUH NW 628, Pittsburgh, PA 15213, USA
b Lung Transplant, University of Pittsburgh Medical Center, 200 Lothrop Street, Suite C-901, Pittsburgh, PA 15213, USA
∗Corresponding author. Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh Medical Center, 3459 Fifth Avenue, MUH NW 628, Pittsburgh, PA 15213.Division of PulmonaryAllergy, Critical Care, and Sleep MedicineDepartment of MedicineUniversity of Pittsburgh Medical Center3459 Fifth Avenue, MUH NW 628PittsburghPA15213
Resumen |
This article reviews the multitude of factors contributing to immune dysfunction and pulmonary infection risk in solid organ transplant recipients and references relevant clinical scientific reports. The mechanisms of action of individual immunosuppressive agents are explained, and the clinical effects of these drugs are compared. In addition, specialized methods to assess the net state of immunosuppression in individual transplant recipients and their limitations are discussed.
El texto completo de este artículo está disponible en PDF.Keywords : SOT, Net state of immunity, Infection, Rejection
Esquema
© 2024
Elsevier Inc. Reservados todos los derechos.
Vol 46 - N° 1
P. 149-158 - mars 2025 Regresar al número
Artículo precedente
- Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy
- Mahnoor Mir, Saadia Faiz, Anuradha G. Bommakanti, Ajay Sheshadri
- Pulmonary Immunocompromise in Chronic and High-dose Steroid Therapy
- Mohleen Kang, Rodrigo Cavallazzi
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?